CLINICAL ANALYSIS OF ASSOCIATION OF CYSTATIN C AND ATRIAL FIBRILLATION

CLINICAL ANALYSIS OF ASSOCIATION OF CYSTATIN C AND ATRIAL FIBRILLATION

Show other versions (1)

Some studies have disclosed atrial fibrillation (AF) is associated with inflammation. Cystatin C is not only inflammatory markers but also an independent predictor of cardiovascular events.Aim. We sought to investigate the relationship between serum levels of cystatin C and the occurrence and develo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ping Liu, Shujian Sui, Dongling Xu
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2014-04-01
Series:	Российский кардиологический журнал
Subjects:	cystatin c atrial fibrillation inflammation inflammatory markers
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/604
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CLINICAL ANALYSIS OF ASSOCIATION OF CYSTATIN C AND ATRIAL FIBRILLATION
by: Ping Liu, et al.
Published: (2014-07-01)

The association between the cystatin C- and creatinine-based estimated GFR ratio and post-ablation outcomes in patients with atrial fibrillation
by: Wenchao Huang, et al.
Published: (2025-12-01)

The role of inflammatory markers in atrial fibrillation: a review
by: S. V. Grigoryan, et al.
Published: (2012-10-01)

REMODELING OF THE HEART AND VESSELS IN ATRIAL FIBRILLATION PATIENTS WITH CHRONIC HEART FAILURE ACCORDING TO CYSTATIN C-RELATED GLOMERULAR FILTRATION RATE
by: S. V. Mironova, et al.
Published: (2018-03-01)

Evaluating the Prognostic Significance of Cystatin C Level Variations Pre‐ and Post‐Radiofrequency Catheter Ablation in the Recurrence of Persistent Atrial Fibrillation
by: Yu‐Yan Zhang, et al.
Published: (2024-11-01)

Inflammation and Nutritional Status Mediated the Increased of Risk of Atrial Fibrillation Recurrence Associated with eGFRdiff Post-Ablation
by: Huang W, et al.
Published: (2024-11-01)

Association between initial serum cystatin C level and prognosis of aneurysmal subarachnoid hemorrhage
by: Ruoran Wang, et al.
Published: (2025-04-01)

Role of inflammatory markers in the pathogenesis and outcome of atrial fibrillation different clinical forms
by: K. G. Adamyan, et al.
Published: (2011-03-01)

The role of inflammatory theory in the pathogenesis of atrial fibrillation
by: K. V. Davtyan, et al.
Published: (2019-08-01)

Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01)

Value of morphological and laboratory markers in predicting the effectiveness of cryoballoon pulmonary vein isolation in atrial fibrillation
by: E. N. Kalemberg, et al.
Published: (2023-06-01)

Relationship between serum inflammatory markers and recurrent atrial fibrillation in patients undergoing pulmonary vein isolation
by: E. N. Tsareva, et al.
Published: (2020-11-01)

The association between blood count based inflammatory markers and the risk of atrial fibrillation heart failure and cardiovascular mortality
by: Yi Luo, et al.
Published: (2025-03-01)

Predictive markers of atrial fibrillation in patients after acute ST-elevated myocardial infarction (the results of observational program “FAKEL”)
by: I. A. Zolotovskaya, et al.
Published: (2018-10-01)

Pathogenic Mechanisms of Atrial Fibrillation in Obesity
by: O. M. Drapkina, et al.
Published: (2016-11-01)

Association Between Serum Uric Acid and Atrial Fibrillation in Patients With Hypertension: A Systematic Review and Meta-Analysis
by: Nianping Tang, et al.
Published: (2025-05-01)

Markers associated with atrial fibrillation in hypertensive patients
by: N. V. Bukvalnaya, et al.
Published: (2025-03-01)

Prognostic value of serum cystatin C in patients with sepsis
by: Chunfang Hu, et al.
Published: (2023-07-01)

Cystatin C as a potential biomarker to evaluate migraine
by: Turan AKDAĞ, et al.

Cystatin C and uncontrolled hypertension
by: Mehmet Onur Omaygenç, et al.
Published: (2020-10-01)

The Role of Cystatin C and Galectin-3 in Cardiorenal Syndrome
by: Nazar Ahemd Naji, et al.
Published: (2023-02-01)

Assessment of Inflammatory Biomarkers and Incident Atrial Fibrillation in Older Adults
by: Sanyog G. Shitole, et al.
Published: (2024-12-01)

Determination of Cystatin C Level in a Sample of Patients with Chronic Kidney Disease
by: Maryam Noman Salman, et al.
Published: (2022-11-01)

Clinical research of blood and urine cystatin C in geriatric sepsis with acute kidney injury
by: ZHU Guo-chao, et al.
Published: (2019-01-01)

The Predictive Power of the Cystatin C‐Creatinine Score in Assessing Frailty
by: Li Deng, et al.
Published: (2025-01-01)

Comparative evaluation of markers of inflammation and fibrosis in patients with various clinical forms of atrial fibrillation
by: S. V. Grigoryan, et al.
Published: (2018-12-01)

Serum cystatin C as a marker of glomerular kidney damage in patients with chronic glomerulonephritis with saved renal function
by: O. V. Kraydashenko, et al.
Published: (2015-06-01)

Clinical prediction study on the risk of atrial fibrillation in hypertensive patients based on metabolism, inflammation, and gender differences
by: Kangming Li, et al.
Published: (2025-04-01)

Possible risk factors for atrial fibrillation in patients with heart failure with mildly reduced ejection fraction
by: L. G. Azarapetyan, et al.
Published: (2024-04-01)

Association between plasma trimethylamine N-oxide level and atrial fibrillation
by: YANG Wentao, ZHAO Qing, LI Xiangdong, WANG Yutang, LIU Wei
Published: (2025-04-01)

Inflammation pathways as therapeutic targets in angiotensin II induced atrial fibrillation
by: Ailin Hou, et al.
Published: (2025-03-01)

Cadmium exposure, epigenetic modifications, and serum cystatin C: insights into mediated pathways and mortality risks in U.S. adults
by: Yu-Wei Fang, et al.
Published: (2025-05-01)

Discordant Results Between Creatinine- and Cystatin C-based Equations for Estimating GFR
by: Pierre Delanaye, et al.
Published: (2025-04-01)

Cystatin C: diagnostic and prognostic value in acute kidney injury
by: D. I. Korabelnikov, et al.
Published: (2024-08-01)

Inflammation and atrial fibrillation
by: Yasushi Mukai
Published: (2024-02-01)

Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies
by: Konstantinos Grigoriou, et al.
Published: (2025-07-01)

Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL)
by: I. A. Zolotovskaya, et al.
Published: (2019-05-01)

Helicobacter pylori and Atrial Fibrillation: Insights into Their Inter-Relationship
by: Weiting Feng, et al.
Published: (2025-04-01)

Expressions of plasma cystatin C, D-dimer and hypersensitive C-reactive protein in patients with intracranial progressive hemorrhagic injury after craniocerebral injury, and their clinical significance
by: Qibin PENG, et al.

Cystatin C in the diagnostics of acute kidney injury after heart transplantation
by: A. G. Strokov, et al.
Published: (2017-04-01)